Enzo Biochem to voluntarily delist from NYSE and transfer trading of shares to OTCQX; shares fall

Written by Emily J. Thompson, Senior Investment Analyst

ENZ%

Source: SeekingAlpha

Updated: Mar 28 2025

0mins

Source: SeekingAlpha

Enzo Biochem Delisting Announcement: Enzo Biochem plans to voluntarily delist its common stock from the NYSE and transition to the OTCQX Best Market, with the delisting expected to take effect around April 17, 2025.
Market Reaction: Following the announcement, ENZ shares experienced a significant decline of over 19% in post-market trading on Friday.

About the author

Emily J. Thompson

Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.

Enzo Biochem to voluntarily delist from NYSE and transfer trading of shares to OTCQX; shares fall

About the author

Top News

Oil Firms Cautious on Venezuela Investment Push

GM Reports $7.1 Billion Charge Amid EV Shift

Stock Market Wraps 2025 with Double-Digit Gains

Novo Nordisk's Weight-Loss Pill Approval: Key Impacts

Related Articles

Monero (XMR) Surges 44% in Five Days, Yet Investment Risks Persist

Trump Proposes Credit Card Rate Cap, Financial Stocks Dip

Sigh Up to Get Intellectia Insights

How did the company's recent strategic decisions impact its latest financial performance?

Can you explain the factors behind the recent changes in the company's stock price?

What are the expected impacts of current market trends on the company's future growth?

Based on the latest earnings report, what are the company's forecasted revenues for the next quarter?

How does the company's performance compare to its main competitors in the same sector?

People Also Watch